Venus Medtech (Hangzhou), Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,328.00
-440.00
-209.00
-432.00
-354.00
-181.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-163.00
-176.00
-155.00
-87.00
-120.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-887.00
-526.00
-265.00
-352.00
-183.00
-96.00
Cash Flow from Investing Activities
-1,249.00
-753.00
-312.00
-35.00
-229.00
-42.00
Cash Flow from Financing Activities
783.00
1,620.00
1,020.00
2,931.00
540.00
189.00
Net Cash Inflow / Outflow
-1,248.00
297.00
333.00
2,549.00
125.00
52.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
105.00
-41.00
-109.00
5.00
-1.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Venus Medtech (Hangzhou), Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-1328.47321613883
109.89042333319
-1,437.00
-1308.91%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-163.24135278411
-13.8704756171587
-150.00
-1076.90%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-887.849363935678
187.219436228288
-1,074.00
-574.23%
Cash Flow from Investing Activities
-1249.73357048203
-869.394646126728
-380.00
-43.75%
Cash Flow from Financing Activities
783.247307157976
-43.4502704883634
826.00
1902.63%
Net Cash Inflow / Outflow
-1248.73814674464
-724.772196222752
-524.00
-72.29%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
105.597480515089
0.853284164050955
105.00
12275.42%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'22
YoY Growth in year ended Dec 2022 is -68.50% vs -98.75% in Dec 2021
Dec'22
Dec'21
Change(%)
Cash Flow from Operating Activities
-887.85
-526.90
-68.50%






